论文部分内容阅读
目的探讨甲状腺功能减退症(甲减)的神经内科治疗方法及效果。方法选取2012年10月~2014年10月本院神经内科接受治疗的80例原发性甲减患者,口服左甲状腺素纳片(优甲乐)治疗,根据复查结果调整剂量,分别于治疗前与治疗6个月后检测患者的血脂、心功能及甲状腺功能指标。结果经过治疗,患者的ApoA-Ⅰ、HDL升高,TG、TC、LDL、ApoB水平降低,与治疗前相比差异有统计学意义(P<0.05);患者的A峰降低,LVEF、LVEDD、E峰、E/A比值升高,与治疗前相比差异有统计学意义(P<0.05);患者的FT_3、FT_4水平升高,TSH水平降低,与治疗前相比差异有统计学意义(P<0.05)。结论采用优甲乐治疗甲减,可促进患者的血脂、心功能及甲状腺功能指标得到改善,良好控制病情,避免引发相关疾病,提高患者的生存质量。
Objective To investigate the methods and effects of neurological treatment of hypothyroidism (hypothyroidism). Methods Eighty patients with primary hypothyroidism treated with neuroleptics in our hospital from October 2012 to October 2014 were treated with oral levothyroxine (Euthyrox), and the dose was adjusted according to the results of the review. Before treatment After 6 months of treatment, the patients’ blood lipids, cardiac function and thyroid function indexes were detected. Results After treatment, the levels of ApoA-I, HDL, TG, TC, LDL and ApoB in patients were lower than those before treatment (P <0.05) (P <0.05). The levels of FT_3 and FT_4 were increased and the level of TSH was decreased in the patients, which was significantly different from that before treatment (P <0.05) P <0.05). Conclusion Euthyrox treatment of hypothyroidism, can promote the patient’s blood lipids, cardiac function and thyroid function index improved, a good control of the disease, to avoid triggering related diseases and improve the quality of life of patients.